Strate­gic Pri­or­i­ties in Can­cer Ther­a­py: Nav­i­gat­ing the 2026 Can­cer Mis­sion Calls

TBC

TBC

TBC

AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection

Moni­ka Ślęzak

Moni­ka joined Łukasiewicz – PORT in March 2022 as Coör­di­na­tor of the Indus­try Con­tact Point for Med­ical Tech­nolo­gies and Health. She has over 10 years of research expe­ri­ence in mol­e­c­u­lar and cel­lu­lar biol­o­gy with­in the drug and vac­cine devel­op­ment field, with a par­tic­u­lar focus on pre­clin­i­cal stud­ies, includ­ing in vit­ro and ani­mal mod­els such as mice and zebrafish.

She earned her PhD in 2009 from the Jagiel­lon­ian Uni­ver­si­ty in Kraków. Her doc­tor­al dis­ser­ta­tion focused on the geno­tox­ic effects of acute car­bon monox­ide poi­son­ing in humans. Since 2008, she has been involved in man­ag­ing research projects fund­ed by the Euro­pean Union, includ­ing Hori­zon 2020, Hori­zon Europe, IMI, and IHI pro­grams, serv­ing as both project man­ag­er and research project leader. Since 2023, she has act­ed as an eval­u­a­tor for com­pe­ti­tions orga­nized by the Euro­pean Commission.

Her pro­fes­sion­al expe­ri­ence includes roles as project leader and senior sci­en­tist at Selvi­ta S.A., one of the largest drug dis­cov­ery com­pa­nies in Cen­tral Europe, based in Kraków, as well as posi­tions at the Mol­e­c­u­lar Biodis­cov­ery Lab at KU Leu­ven in Bel­gium and the Euro­pean Vac­cine Ini­tia­tive eV in Hei­del­berg, Germany.

She com­plet­ed post­grad­u­ate stud­ies in project man­age­ment and research com­mer­cial­iza­tion at the Cra­cow Uni­ver­si­ty of Eco­nom­ics (2011) and obtained the IPMA Project Man­ag­er Asso­ciate cer­tifi­cate the same year. In 2018, she com­plet­ed spe­cial­ized train­ing in Good Clin­i­cal Prac­tice through the CRA Train­ing pro­gram at Phar­maakademie in Mannheim.

Monika Ślęzak
Moni­ka Ślęzak, Indus­try Con­tact Point, Łukasiewicz — PORT, POLAND

Read the Abstracts from Our Invit­ed Speakers

Can­cer Biology

Can­cer Neuroscience

Can­cer Therapy

PORT for Busi­ness — Com­pa­ny Session